Nutriband Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Nutriband Inc. on August 16, 2022. The company is incorporated in Nevada and maintains its principal executive offices in Orlando, Florida. Its common stock (NTRB) and warrants (NTRBW) are registered on The Nasdaq Stock Market LLC. The filing primarily addresses unregistered sales of equity securities and compensatory arrangements for directors and officers.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. This report focuses exclusively on the issuance of stock options rather than financial performance results.
Material Changes and Corporate Actions
On August 16, 2022, the Board of Directors ratified the issuance of Option Award Agreements to officers and directors, originally approved by the Compensation Committee on August 1, 2022. These grants were made in consideration for services rendered in fiscal 2023. The share counts listed below have been adjusted for a 7-for-6 forward stock split effective August 12, 2022.
| Recipient | Title | Shares Granted | Exercise Price |
|---|---|---|---|
| Gareth Sheridan | CEO | 29,167 | $4.50 |
| Serguei Melnik | Chairman and President | 29,167 | $4.50 |
| Gerald Goodman | CFO | 23,333 | $4.09 |
| Alan Smith | COO | 11,667 | $4.09 |
| Jeff Patrick | Chief Scientific Officer | 23,337 | $4.09 |
| Patrick Ryan | Chief Technical Officer | 11,667 | $4.09 |
| Dianna Mather | Director | 8,750 | $4.09 |
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, risks, contingencies, or unusual items. The document is strictly a disclosure of the equity compensation event.
Key Facts for Investor Verification
- Verify the impact of the 7-for-6 forward stock split (effective August 12, 2022) on the exercise prices and share counts of existing and new options.
- Confirm the total dilution effect of the 137,088 options granted to key personnel.
- Review the specific vesting schedules and expiration terms of the Option Award Agreements, which are not detailed in this summary text.
- Check subsequent filings for the company's financial performance for the period ending August 2022, as this 8-K contains no financial data.